Bellevue Asset Management has launched a Luxembourg-domiciled version of its BB Adamant Global Healthcare Index fund, the Zurich-based firm has announced.
The BB Adamant Healthcare Index (Lux) fund, which was registered for public distribution at the end of 2016, is run by Cyrill Zimmermann, head of healthcare funds and mandates at Bellevue Asset Management and his team.
The move to expand the strategy’s distribution reach comes a few months shy of the index’s ten-year anniversary in April 2017.
This new index-based approach holds a total of 40 healthcare stocks in the global universe.
The BB Adamant Healthcare Team screens 600 of the 3000 listed companies in the healthcare sector and picks the top ten stocks from each of four regions.
These include Western Europe, North America, Japan/Australia and emerging markets.
While North America is typically the region with the highest score, the index puts an emphasis on emerging markets by placing a maximum weighting for North America at 35% when the index is rebalanced.
In fact, the Asian region has typically accounted for a third of the index.
Over three years to the end of November, the BB Adamant Global Healthcare Index returned 35.07%, compared its benchmark, the MSCI World/Health Care TR, which returned 36.09% over the same timeframe.
The announcement comes as part of a long-running initiative to widen the reach of the index as, in 2011, Bellevue launched a Swiss investment fund for institutional investors which also replicated the index.
Commenting on the new launch, Zimmermann said: 'A growing number of investors had asked us to offer an index product outside Switzerland too.
'This is an important addition to our diverse range of sound investment solutions. The fund effectively covers all of the high growth segments within the promising healthcare industry on a global scale.'
The Bellevue fund is has been approved for sale to retail investors in Germany, Switzerland, Austria and Luxembourg.